-
1.发明申请PHARMACEUTICAL COMPOSITION COMPRISING A SELECTIVE I1 IMIDAZOLINE RECEPTOR AGONIST AND AN ANGIOTENSIN II RECEPTOR BLOCKER 审中-公开包含选择性I1咪唑啉受体激动剂和ANGIOTENSIN II受体阻断剂的药物组合物
公开(公告)号：WO2005039639A3
公开(公告)日：2005-08-11
申请号：PCT/EP2004052468
申请日：2004-10-07
Applicant: SOLVAY PHARM GMBH
Inventor： BAUM DOMINIQUE , BIELENBERG GERHARD-WILHELM , BOEDECKER BERND , THORMAEHLEN DIRK
IPC: A61K31/4172 , A61K31/4178 , A61K31/4184 , A61K31/506 , A61K45/06 , A61P9/14
CPC classification number: A61K45/06 , A61K31/4178 , A61K31/506 , A61K2300/00
Abstract: The present invention relates to pharmaceutical compositions comprising selective imidazoline receptor agonists combined with angiotensin II receptor blockers. In particular, the present invention relates to pharmaceutical compositions comprising Moxonidine and Eprosartan mesylate. The invention also relates to the use of said compositions in the manufacture of a medicament for the treatment of hypertension, especially in hypertensive patients already suffering from type II diabetes or being susceptible to developing type II diabetes.
Abstract translation: 本发明涉及包含与血管紧张素II受体阻断剂组合的选择性咪唑啉受体激动剂的药物组合物。 特别地，本发明涉及包含莫索尼定和甲磺酸依普罗沙坦的药物组合物。 本发明还涉及所述组合物在制备用于治疗高血压的药物中的用途，特别是在已经患有II型糖尿病或易于发展为II型糖尿病的高血压患者中。
-
2.发明申请PHARMACEUTICAL COMPOSITION COMPRISING A SELECTIVE I1 IMIDAZOLINE RECEPTOR AGONIST AND AN ANGIOTENSIN II RECEPTOR BLOCKER 审中-公开包含选择性I1咪唑啉受体激动剂和血管紧张素II受体阻滞剂的药物组合物
公开(公告)号：WO2005039639B1
公开(公告)日：2005-09-22
申请号：PCT/EP2004052468
申请日：2004-10-07
Applicant: SOLVAY PHARM GMBH
Inventor： BAUM DOMINIQUE , BIELENBERG GERHARD-WILHELM , BOEDECKER BERND , THORMAEHLEN DIRK
IPC: A61K31/4172 , A61K31/4178 , A61K31/4184 , A61K31/506 , A61K45/06 , A61P9/14
CPC classification number: A61K45/06 , A61K31/4178 , A61K31/506 , A61K2300/00
Abstract: The present invention relates to pharmaceutical compositions comprising selective imidazoline receptor agonists combined with angiotensin II receptor blockers. In particular, the present invention relates to pharmaceutical compositions comprising Moxonidine and Eprosartan mesylate. The invention also relates to the use of said compositions in the manufacture of a medicament for the treatment of hypertension, especially in hypertensive patients already suffering from type II diabetes or being susceptible to developing type II diabetes.
Abstract translation: 本发明涉及包含与血管紧张素II受体阻滞剂组合的选择性咪唑啉受体激动剂的药物组合物。 具体而言，本发明涉及包含莫索尼定和甲磺酸普罗沙坦的药物组合物。 本发明还涉及所述组合物在制备用于治疗高血压的药物中的用途，所述药物尤其是已经患有II型糖尿病或易患II型糖尿病的高血压患者。
-
公开(公告)号：CA2541867A1
公开(公告)日：2005-05-06
申请号：CA2541867
申请日：2004-10-07
Applicant: SOLVAY PHARM GMBH
Inventor： BIELENBERG GERHARD-WILHELM , BAUM DOMINIQUE , THORMAEHLEN DIRK , BOEDECKER BERND
IPC: A61K45/06 , A61K31/4172 , A61K31/4178 , A61K31/4184 , A61K31/506 , A61P9/14
Abstract: Pharmaceutical compositions containing selective imidazoline receptor agonists combined with angiotensin II receptor blockers, particularly, pharmaceutical compositions containing Moxonidine and Eprosartan mesylate, as well as the use of such compositions for the treatment of hypertension, especially in hypertensive patients suffering from type II diabetes or susceptible to developing type II diabetes.
-
公开(公告)号：ES2304624T3
公开(公告)日：2008-10-16
申请号：ES04766880
申请日：2004-10-07
Applicant: SOLVAY PHARM GMBH
Inventor： BAUM DOMINIQUE , BIELENBERG GERHARD-WILHELM , BOEDECKER BERND , THORMAEHLEN DIRK
IPC: A61K45/06 , A61K31/4172 , A61K31/4178 , A61K31/4184 , A61K31/506 , A61P9/14
Abstract: Una composición farmacéutica que comprende Moxonidina o una de sus sales farmacéuticamente aceptables en calidad de un agonista selectivo del receptor de imidazolina I1 y Eprosartán o una de sus sales farmacéuticamente aceptables en calidad de un bloqueante del receptor de angiotensina II y un excipiente farmacéuticamente aceptable.
-
公开(公告)号：AT390148T
公开(公告)日：2008-04-15
申请号：AT04766880
申请日：2004-10-07
Applicant: SOLVAY PHARM GMBH
Inventor： BAUM DOMINIQUE , BIELENBERG GERHARD-WILHELM , BOEDECKER BERND , THORMAEHLEN DIRK
IPC: A61K45/06 , A61K31/4172 , A61K31/4178 , A61K31/4184 , A61K31/506 , A61P9/14
Abstract: Pharmaceutical compositions containing selective imidazoline receptor agonists combined with angiotensin II receptor blockers, particularly, pharmaceutical compositions containing Moxonidine and Eprosartan mesylate, as well as the use of such compositions for the treatment of hypertension, especially in hypertensive patients suffering from type II diabetes or susceptible to developing type II diabetes.
-
Patent Agency Ranking
公开(公告)号：BRPI0415198A
公开(公告)日：2006-12-05
申请号：BRPI0415198
申请日：2004-10-07
Applicant: SOLVAY PHARM GMBH
Inventor： BAUM DOMINIQUE , BIELENBERG GERHARD-WILHELM , BOEDECKER BERND , THORMAEHLEN DIRK
IPC: A61K31/4172 , A61K31/4178 , A61K31/4184 , A61K31/506 , A61K45/06 , A61P9/14
Abstract: Pharmaceutical compositions containing selective imidazoline receptor agonists combined with angiotensin II receptor blockers, particularly, pharmaceutical compositions containing Moxonidine and Eprosartan mesylate, as well as the use of such compositions for the treatment of hypertension, especially in hypertensive patients suffering from type II diabetes or susceptible to developing type II diabetes.
-
公开(公告)号：CA2541867C
公开(公告)日：2012-06-12
申请号：CA2541867
申请日：2004-10-07
Applicant: SOLVAY PHARM GMBH
Inventor： BAUM DOMINIQUE , BIELENBERG GERHARD-WILHELM , BOEDECKER BERND , THORMAEHLEN DIRK
IPC: A61K45/06 , A61K31/4172 , A61K31/4178 , A61K31/4184 , A61K31/506 , A61P9/14
Abstract: The present invention relates to pharmaceutical compositions comprising selective imidazoline receptor agonists combined with angiotensin II receptor blockers. In particular, the present invention relates to pharmaceutical compositions comprising Moxonidine and Eprosartan mesylate. The invention also relates to the use of said compositions in the manufacture of a medicament for the treatment of hypertension, especially in hypertensive patients already suffering from type II diabetes or being susceptible to developing type II diabetes.
-
公开(公告)号：AU2004283047A1
公开(公告)日：2005-05-06
申请号：AU2004283047
申请日：2004-10-07
Applicant: SOLVAY PHARM GMBH
Inventor： BOEDECKER BERND , BAUM DOMINIQUE , BIELENBERG GERHARD-WILHELM , THORMAEHLEN DIRK
IPC: A61K31/506 , A61K31/4172 , A61K31/4178 , A61K31/4184 , A61K45/06
Abstract: Pharmaceutical compositions containing selective imidazoline receptor agonists combined with angiotensin II receptor blockers, particularly, pharmaceutical compositions containing Moxonidine and Eprosartan mesylate, as well as the use of such compositions for the treatment of hypertension, especially in hypertensive patients suffering from type II diabetes or susceptible to developing type II diabetes.
-
公开(公告)号：DE602004012763T2
公开(公告)日：2009-05-07
申请号：DE602004012763
申请日：2004-10-07
Applicant: SOLVAY PHARM GMBH
Inventor： BAUM DOMINIQUE , BIELENBERG GERHARD-WILHELM , BOEDECKER BERND , THORMAEHLEN DIRK
IPC: A61K45/06 , A61K31/4172 , A61K31/4178 , A61K31/4184 , A61K31/506 , A61P9/14
Abstract: Pharmaceutical compositions containing selective imidazoline receptor agonists combined with angiotensin II receptor blockers, particularly, pharmaceutical compositions containing Moxonidine and Eprosartan mesylate, as well as the use of such compositions for the treatment of hypertension, especially in hypertensive patients suffering from type II diabetes or susceptible to developing type II diabetes.
-
公开(公告)号：DE602004012763D1
公开(公告)日：2008-05-08
申请号：DE602004012763
申请日：2004-10-07
Applicant: SOLVAY PHARM GMBH
Inventor： BAUM DOMINIQUE , BIELENBERG GERHARD-WILHELM , BOEDECKER BERND , THORMAEHLEN DIRK
IPC: A61K45/06 , A61K31/4172 , A61K31/4178 , A61K31/4184 , A61K31/506 , A61P9/14
Abstract: Pharmaceutical compositions containing selective imidazoline receptor agonists combined with angiotensin II receptor blockers, particularly, pharmaceutical compositions containing Moxonidine and Eprosartan mesylate, as well as the use of such compositions for the treatment of hypertension, especially in hypertensive patients suffering from type II diabetes or susceptible to developing type II diabetes.
-
-
-
-
-
-
-
-
-
Search Results
11
records
(took 0.023 seconds)
